29.10.1982
737 4268
lorena.simon.gracia@ut.ee

Career

Institutions and positions
16.09.2019–...   
University of Tartu, Faculty of Medicine, Institute of Biomedicine and Translational Medicine, Senior Research Fellow of Cancer Biology (1,00)
01.01.2016–...   
University of Tartu, Faculty of Medicine, Institute of Biomedicine and Translational Medicine, Research Fellow of Cancer Biology (1,00)
01.07.2018–15.09.2019   
University of Tartu, Faculty of Medicine, Institute of Biomedicine and Translational Medicine, Research Fellow of Cancer Biology (1,00)
02.01.2018–30.06.2018   
NCI Designated Cancer Center Sanford Burnham Prebys Medical Discovery Institute, La Jolla, USA, Post-doctoral Visit (1,00)
01.01.2018–30.06.2018   
University of Tartu, Faculty of Medicine, Institute of Biomedicine and Translational Medicine, Research Fellow of Cancer Biology (0,25)
01.07.2017–15.09.2017   
Department of Chemistry, University College London, UK. Molecular Bionic Labs, Visiting Researcher (1,00)
07.01.2017–30.03.2017   
CIC biomaGUNE, San Sebastian, Spain. Soft Matter Nanotechnology Lab, Visiting Researcher (1,00)
01.09.2015–31.12.2015   
University of Tartu, Faculty of Medicine, Institute of Biomedicine, Research Fellow of Cancer Biology (1,00)
01.11.2014–23.12.2014   
Department of Chemistry and Biochemistry. University of California San Diego, California, USA, Visiting Researcher (0,50)
01.11.2014–23.12.2014   
NCI Designated Cancer Center Sanford Burnham Prebys Medical Discovery Institute, La Jolla, USA, Visiting Researcher (0,50)
21.05.2013–31.08.2015   
University of Tartu, Faculty of Medicine, Institute of Biomedicine, Research Fellow (1,00)
01.10.2012–20.05.2013   
University of Tartu, Faculty of Medicine, Departement of General and Molecular Pathology, Research Fellow (1,00)
01.09.2012–30.09.2012   
University of Tartu, Faculty of Medicine, Departement of General and Molecular Pathology, Research Fellow (1,00)
01.01.2011–01.08.2012   
Institute for Research in Biomedicine, University of Barcelona, Researcher (1,00)
01.03.2010–01.07.2010   
Department of Chemistry, University of Sheffield, Doctoral Stay abroad (1,00)
 
 
Education
2007–30.09.2011   
PhD at the University of Barcelona
15.09.2004–15.09.2008   
Bachelor Degree in Biochemistry
15.09.2000–20.07.2005   
Bachelor Degree in Chemistry
 
 
Additional information
Conference "Frontiers in Delivery of Therapeutics". August 2018, Tartu, Estonia;
Spring workshop in Tartu: "Targeting nanosystems for imaging and therapy". May 2017, Tartu, Estonia. Organizer of the workshop;
Gordon Research Seminars: Drug Carriers in Medicine & Biology. August 2016. New Hampshire, USA. Invited speaker for oral presentation. “pH-sensitive polymersomes targeted with CendR peptides for treatment of peritoneal carcinomatosis”;
Gordon Research Conference: Drug Carriers in Medicine & Biology. August 2016. New Hampshire, USA. Poster presentation. “pH-sensitive polymersomes targeted with CendR peptides for treatment of peritoneal carcinomatosis”;
11th International Symposium on Polymer Therapeutics: From Laboratory to Clinical Practice. May 2016. Valencia, Spain. Oral presentation. “pH-sensitive polymersomes targeted with CendR peptides for treatment of peritoneal carcinomatosis”;
NanoBioMed. Nanobiologia y Nanomedicina. November 2015. Barcelona, Spain. Oral presentation. “Tumor penetrating polymersomes for cancer theranostics”;
EMN Cancun Meeting. Energy Materials Nanotechnology. June 2015. Cancun, Mexico. Oral presentation: “Tumor penetrating pH-sensitive polymersomes for intraperitoneal tumor theranostics” ;
The European Summit for Clinical Nanomedicine and Targeted Medicine. “Paving the way to personalized diagnostics and therapy”. CLINAM (European Foundation for Clinical Nanomedicine). June 2014, Basel, Switzerland. Poster presentation: “Tumor penetrating pH-sensitive polymersomes for cancer theranostics”;
Special Symposium of the Finish Peptide Society. December 2013, Helsinki. Plenary lecture: “Peptide-mediated targeted drug delivery systems for cancer therapy” ;

Qualifications

 
 
Honours & awards
2017, Lorena Simon Gracia, Post-doctoral fellowship Mobilitas Plus (MOBJD11) Institution: Estonian Government
2014, Lorena Simon Gracia, Swiss funded SCOPES Programme of the Swiss National Foundation. Fellowship for the assistance of The European Summit for Clinical Nanomedicine and Targeted Medicine (CLINAM). Switzerland, June 2014.
2010, Lorena Simon Gracia, PhD Fellowship for foreign stays (BE-DGR 2010-Grant for research in a foreign country) Institution: Catalan Government (Generalitat de Catalunya)
2007, Lorena Simon Gracia, PhD Fellowship (FI-DGR 2007-Investigator formation) Institution: Catalan Government (Generalitat de Catalunya)
 
 
Fields of research
ETIS CLASSIFICATION: 4. Natural Sciences and Engineering; 4.11. Chemistry and Chemical Technology; CERCS CLASSIFICATION: P390 Organic chemistry
 
 

Completed projects

Publications

Category
Year
Publication
 
1.1.
2019
1.1.
2019
1.1.
2018
1.1.
2018
1.1.
2018
1.1.
2017
1.1.
2017
1.1.
2017
1.1.
2017
3.1.
2017
1.1.
2016
1.1.
2016
1.1.
2015
1.1.
2015
1.1.
2014
1.1.
2013
1.1.
2013
1.1.
2011
17.12.2019
29.10.1982
737 4268
lorena.simon.gracia@ut.ee

Teenistuskäik

Töökohad ja ametid
16.09.2019–...   
Tartu Ülikool, Meditsiiniteaduste valdkond, bio- ja siirdemeditsiini instituut, vähibioloogia vanemteadur (1,00)
01.01.2016–...   
Tartu Ülikool, Meditsiiniteaduste valdkond, bio- ja siirdemeditsiini instituut, vähibioloogia teadur (1,00)
01.07.2018–15.09.2019   
Tartu Ülikool, Meditsiiniteaduste valdkond, bio- ja siirdemeditsiini instituut, vähibioloogia teadur (1,00)
02.01.2018–30.06.2018   
NCI Designated Cancer Center Sanford Burnham Prebys Medical Discovery Institute, La Jolla, USA, Post-doctoral Visit (1,00)
01.01.2018–30.06.2018   
Tartu Ülikool, Meditsiiniteaduste valdkond, bio- ja siirdemeditsiini instituut, vähibioloogia teadur (0,25)
01.07.2017–15.09.2017   
Department of Chemistry, University College London, UK. Molecular Bionic Labs, Külalisteadur (1,00)
07.01.2017–30.03.2017   
CIC biomaGUNE, San Sebastian, Spain. Soft Matter Nanotechnology Lab, Külalisteadur (1,00)
01.09.2015–31.12.2015   
Tartu Ülikool, Arstiteaduskond, Biomeditsiini instituut, vähibioloogia teadur (1,00)
01.11.2014–23.12.2014   
Department of Chemistry and Biochemistry. University of California San Diego, California, USA, Külalisteadur (0,50)
01.11.2014–23.12.2014   
NCI Designated Cancer Center Sanford Burnham Prebys Medical Discovery Institute, La Jolla, USA, Külalisteadur (0,50)
21.05.2013–31.08.2015   
Tartu Ülikool, Arstiteaduskond, Biomeditsiini instituut, teadur (1,00)
01.10.2012–20.05.2013   
Tartu Ülikool, Arstiteaduskond, Üld- ja molekulaarpatoloogia instituut, teadur (1,00)
01.09.2012–30.09.2012   
Tartu Ülikool, Arstiteaduskond, Üld- ja molekulaarpatoloogia instituut, teadur (1,00)
01.01.2011–01.08.2012   
Institute for Research in Biomedicine, University of Barcelona, Teadur (1,00)
01.03.2010–01.07.2010   
Department of Chemistry, University of Sheffield, Doctoral Stay abroad (1,00)
 
 
Haridustee
2007–30.09.2011   
PhD at the University of Barcelona
15.09.2004–15.09.2008   
Bachelor Degree in Biochemistry
15.09.2000–20.07.2005   
Bachelor Degree in Chemistry
 
 
Lisainfo
Conference "Frontiers in Delivery of Therapeutics". August 2018, Tartu, Estonia;
Spring workshop in Tartu: "Targeting nanosystems for imaging and therapy". May 2017, Tartu, Estonia. Organizer of the workshop;
Gordon Research Seminars: Drug Carriers in Medicine & Biology. August 2016. New Hampshire, USA. Invited speaker for oral presentation. “pH-sensitive polymersomes targeted with CendR peptides for treatment of peritoneal carcinomatosis”;
Gordon Research Conference: Drug Carriers in Medicine & Biology. August 2016. New Hampshire, USA. Poster presentation. “pH-sensitive polymersomes targeted with CendR peptides for treatment of peritoneal carcinomatosis”;
11th International Symposium on Polymer Therapeutics: From Laboratory to Clinical Practice. May 2016. Valencia, Spain. Oral presentation. “pH-sensitive polymersomes targeted with CendR peptides for treatment of peritoneal carcinomatosis”;
NanoBioMed. Nanobiologia y Nanomedicina. November 2015. Barcelona, Spain. Oral presentation. “Tumor penetrating polymersomes for cancer theranostics”;
EMN Cancun Meeting. Energy Materials Nanotechnology. June 2015. Cancun, Mexico. Oral presentation: “Tumor penetrating pH-sensitive polymersomes for intraperitoneal tumor theranostics” ;
The European Summit for Clinical Nanomedicine and Targeted Medicine. “Paving the way to personalized diagnostics and therapy”. CLINAM (European Foundation for Clinical Nanomedicine). June 2014, Basel, Switzerland. Poster presentation: “Tumor penetrating pH-sensitive polymersomes for cancer theranostics”;
Special Symposium of the Finish Peptide Society. December 2013, Helsinki. Plenary lecture: “Peptide-mediated targeted drug delivery systems for cancer therapy” ;

Kvalifikatsioon

 
 
Teaduspreemiad ja tunnustused
2017, Lorena Simon Gracia, Post-doctoral fellowship Mobilitas Plus (MOBJD11) Institution: Estonian Government
2014, Lorena Simon Gracia, Swiss funded SCOPES Programme of the Swiss National Foundation. Fellowship for the assistance of The European Summit for Clinical Nanomedicine and Targeted Medicine (CLINAM). Switzerland, June 2014.
2010, Lorena Simon Gracia, PhD Fellowship for foreign stays (BE-DGR 2010-Grant for research in a foreign country) Institution: Catalan Government (Generalitat de Catalunya)
2007, Lorena Simon Gracia, PhD Fellowship (FI-DGR 2007-Investigator formation) Institution: Catalan Government (Generalitat de Catalunya)
 
 
Teadustöö põhisuunad
ETIS KLASSIFIKAATOR: 4. Loodusteadused ja tehnika; 4.11. Keemia ja keemiatehnika; CERCS KLASSIFIKAATOR: P390 Orgaaniline keemia

Lõppenud projektid

Publikatsioonid

Klass
Aasta
Publikatsioon
 
1.1.
2019
1.1.
2019
1.1.
2018
1.1.
2018
1.1.
2018
1.1.
2017
1.1.
2017
1.1.
2017
1.1.
2017
3.1.
2017
1.1.
2016
1.1.
2016
1.1.
2015
1.1.
2015
1.1.
2014
1.1.
2013
1.1.
2013
1.1.
2011
17.12.2019
  • Found 8 results
ProgramTypeNumberNameProject startProject endPrincipal investigatorInstitutionFinancing
MUUMARMP11194RDevelopment of tumor penetrating peptides for glioma targeting01.01.201231.12.2016Tambet TeesaluUniversity of Tartu, Faculty of Medicine, Departement of General and Molecular Pathology; University of Tartu, Faculty of Medicine, Institute of Biomedicine and Translational Medicine; University of Tartu, Faculty of Medicine, Institute of Biomedicine and Translational Medicine1 499 931,00 EUR
MUUMARMP11197Brain tumor penetrating peptides01.01.201231.12.2016Tambet TeesaluUniversity of Tartu, Faculty of Medicine, Institute of Biomedicine; University of Tartu, Faculty of Medicine, Institute of Biomedicine and Translational Medicine; University of Tartu, Faculty of Medicine, Institute of Biomedicine and Translational Medicine250 000,00 EUR
PRGPRG230Homing peptides for targeted delivery of compounds across the blood-brain barrier01.01.201831.12.2022Tambet TeesaluUniversity of Tartu, Faculty of Medicine, Institute of Biomedicine and Translational Medicine649 875,00 EUR
1.2.3.4.MMVBS18435R (823879)Hemoglobin based Protein Nanocarriers for Tumour Oxygenation and a more effective Photodynamic Therapy01.03.201928.02.2023Tambet TeesaluUniversity of Tartu, Faculty of Medicine, Institute of Biomedicine and Translational Medicine156 400,00 EUR
MUUMARBS13184RBinding-activated fluorescent DNA/peptide chimeric probes for cancer imaging01.11.201331.10.2016Tambet TeesaluUniversity of Tartu, Faculty of Medicine, Institute of Biomedicine and Translational Medicine; University of Tartu, Faculty of Medicine, Institute of Biomedicine and Translational Medicine; University of Tartu, Faculty of Medicine, Institute of Biomedicine54 600,00 EUR
MUUMARMP12102Development of tissue penetrating peptides for targeted drug delivery01.06.201231.05.2017Tambet TeesaluUniversity of Tartu, Faculty of Medicine, Institute of Biomedicine and Translational Medicine; University of Tartu, Faculty of Medicine, Institute of Biomedicine; University of Tartu, Faculty of Medicine, Institute of Biomedicine and Translational Medicine1 303 951,00 EUR
MOBJDMOBJD11POLYMERIC NANOPARTICLES FOR GLIOBLASTOMA TREATMENT16.09.201715.09.2019Lorena Simon GraciaUniversity of Tartu, Faculty of Medicine, Institute of Biomedicine and Translational Medicine65 835,00 EUR
EAGEAG79Development of extracellular matrix-targeting precision cancer therapy01.01.202031.12.2020Tambet TeesaluUniversity of Tartu, Faculty of Medicine, Institute of Biomedicine and Translational Medicine100 000,00 EUR